• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

采用药物/SBE-β-CD/共聚维酮 K30 包合方法提高法莫替丁的水溶性并掩蔽其苦味。

Enhancement of the aqueous solubility and masking the bitter taste of famotidine using drug/SBE-beta-CyD/povidone K30 complexation approach.

机构信息

Department of Pharmaceutics, Faculty of Pharmacy, El-Minia University, El-Minia Governate 61732, Egypt.

出版信息

J Pharm Sci. 2010 Oct;99(10):4285-94. doi: 10.1002/jps.22153.

DOI:10.1002/jps.22153
PMID:20737636
Abstract

The objective of the present study was to evaluate the potential of ternary system (comprised of famotidine, beta-cyclodextrin (beta-CyD) or its derivatives and a hydrophilic polymer) as an approach for enhancing the aqueous solubility and masking the bitter taste of famotidine. The aqueous solubility of famotidine increased in the presence of beta-CyDs, particularly sulfobutyl ether beta-CyD (SBE-beta-CyD), and it was further enhanced by the combination of SBE-beta-CyD and polyvinyl pyrrolidone (Povidone) K30. The solid binary (drug-beta-CyDs) and ternary (drug-beta-CyDs-Povidone K30) systems were prepared by the kneading and freeze-drying methods. The dissolution rates of these solid systems were much faster than that of the drug alone. A taste perception study was carried out, initially using a taste sensory machine and subsequently on human volunteers to evaluate the taste masking ability of the ternary complexation. Our results indicated that the combination of SBE-beta-CyD and Povidone K30 is effective not only in the enhancement of the solubility and dissolution rate of famotidine, but also in masking of the bitter taste of the drug. This technique may be of value for the pharmaceutical industries, especially in preparation of rapidly disintegrating tablets dealing with bitter drugs to improve patient compliance and thus effective pharmacotherapy.

摘要

本研究的目的是评估三元体系(由法莫替丁、β-环糊精(β-CyD)或其衍生物和亲水性聚合物组成)作为一种提高法莫替丁水溶性和掩盖其苦味的方法的潜力。β-CyD 的存在可增加法莫替丁的水溶性,特别是磺丁基醚-β-环糊精(SBE-β-CyD),并且 SBE-β-CyD 与聚乙烯吡咯烷酮(Povidone)K30 的组合可进一步增强其水溶性。通过捏合和冷冻干燥方法制备了固体二元(药物-β-CyD)和三元(药物-β-CyD-Povidone K30)系统。这些固体系统的溶解速率比单独的药物快得多。进行了味觉感知研究,最初使用味觉感知机,然后在人体志愿者上进行,以评估三元络合的掩味能力。我们的结果表明,SBE-β-CyD 和 Povidone K30 的组合不仅有效提高了法莫替丁的溶解度和溶解速率,而且掩盖了药物的苦味。该技术可能对制药行业具有价值,特别是在制备用于改善患者顺应性和有效药物治疗的快速崩解片时,处理苦味药物。

相似文献

1
Enhancement of the aqueous solubility and masking the bitter taste of famotidine using drug/SBE-beta-CyD/povidone K30 complexation approach.采用药物/SBE-β-CD/共聚维酮 K30 包合方法提高法莫替丁的水溶性并掩蔽其苦味。
J Pharm Sci. 2010 Oct;99(10):4285-94. doi: 10.1002/jps.22153.
2
Evaluation of carboxymethyl-beta-cyclodextrin with acid function: improvement of chemical stability, oral bioavailability and bitter taste of famotidine.评价具有酸性官能团的羧甲基-β-环糊精:改善法莫替丁的化学稳定性、口服生物利用度和苦味。
Int J Pharm. 2010 Sep 15;397(1-2):1-8. doi: 10.1016/j.ijpharm.2010.06.018. Epub 2010 Jun 19.
3
Preparation and evaluation of taste masked famotidine formulation using drug/beta-cyclodextrin/polymer ternary complexation approach.采用药物/β-环糊精/聚合物三元络合方法制备掩味法莫替丁制剂并进行评价。
AAPS PharmSciTech. 2008;9(2):544-50. doi: 10.1208/s12249-008-9078-0. Epub 2008 Apr 22.
4
Formulation and biological evaluation of glimepiride-cyclodextrin-polymer systems.格列美脲-环糊精-聚合物体系的制剂与生物学评价
Int J Pharm. 2006 Feb 17;309(1-2):129-38. doi: 10.1016/j.ijpharm.2005.11.024. Epub 2005 Dec 27.
5
Slow-release of famotidine from tablets consisting of chitosan/sulfobutyl ether β-cyclodextrin composites.法莫替丁从由壳聚糖/磺丁基醚β-环糊精复合材料制成的片剂中的缓释。
Int J Pharm. 2015 Jun 20;487(1-2):142-7. doi: 10.1016/j.ijpharm.2015.04.022. Epub 2015 Apr 13.
6
Improvement of some physicochemical properties of arundic acid, (R)-(-)-2-propyloctanonic acid, by complexation with hydrophilic cyclodextrins.通过与亲水性环糊精的包合作用来改善芦竹碱、(R)-(-)-2-丙基辛烷酸的一些物理化学性质。
Int J Pharm. 2011 Jul 15;413(1-2):63-72. doi: 10.1016/j.ijpharm.2011.04.022. Epub 2011 Apr 21.
7
Stabilizing and solubilizing effects of sulfobutyl ether beta-cyclodextrin on prostaglandin E1 analogue.磺丁基醚-β-环糊精对前列腺素E1类似物的稳定和增溶作用
Pharm Res. 2001 Nov;18(11):1578-85. doi: 10.1023/a:1013034615464.
8
Implication of inclusion complexation of glimepiride in cyclodextrin-polymer systems on its dissolution, stability and therapeutic efficacy.格列美脲在环糊精 - 聚合物体系中的包合作用对其溶出度、稳定性及治疗效果的影响。
Int J Pharm. 2006 Aug 31;320(1-2):53-7. doi: 10.1016/j.ijpharm.2006.04.002. Epub 2006 Apr 18.
9
Influence of preparation methodology on solid-state properties of an acidic drug-cyclodextrin system.制备方法对酸性药物-环糊精体系固态性质的影响。
J Pharm Pharmacol. 2004 Jun;56(6):725-33. doi: 10.1211/0022357023538.
10
The formation of an inclusion complex between a metabolite of ginsenoside, compound K and γ-cyclodextrin and its dissolution characteristics.人参皂苷代谢物化合物K与γ-环糊精之间包合物的形成及其溶解特性。
J Pharm Pharmacol. 2016 May;68(5):646-54. doi: 10.1111/jphp.12468. Epub 2015 Aug 10.

引用本文的文献

1
Cyclodextrins: Enhancing Drug Delivery, Solubility and Bioavailability for Modern Therapeutics.环糊精:提升现代治疗药物的递送、溶解度及生物利用度。
Pharmaceutics. 2025 Feb 22;17(3):288. doi: 10.3390/pharmaceutics17030288.
2
Development of α-Cyclodextrin-Based Orally Disintegrating Tablets for 4-Phenylbutyrate.用于4-苯基丁酸的基于α-环糊精的口腔崩解片的研制。
Pharmaceutics. 2024 Jan 7;16(1):82. doi: 10.3390/pharmaceutics16010082.
3
Review of Applications of Cyclodextrins as Taste-Masking Excipients for Pharmaceutical Purposes.
环糊精作为掩味药用辅料的应用综述。
Molecules. 2023 Oct 7;28(19):6964. doi: 10.3390/molecules28196964.
4
Evaluation of the taste-masking effects of (2-hydroxypropyl)-β-cyclodextrin on ranitidine hydrochloride; a combined biosensor, spectroscopic and molecular modelling assessment.(2-羟丙基)-β-环糊精对盐酸雷尼替丁的掩味效果评估;生物传感器、光谱和分子模拟联合评估
RSC Adv. 2018 Jan 17;8(7):3564-3573. doi: 10.1039/c7ra11015d. eCollection 2018 Jan 16.
5
Design of 3-aminophenol-grafted polymer-modified zinc sulphide nanoparticles as drug delivery system.3-氨基酚接枝聚合物修饰的硫化锌纳米粒子的药物传递系统设计。
IET Nanobiotechnol. 2021 Oct;15(8):664-673. doi: 10.1049/nbt2.12063. Epub 2021 Jun 11.
6
Solubilized ubiquinol for preserving corneal function.溶解态泛醇对角膜功能的保护作用。
Biomaterials. 2021 Aug;275:120842. doi: 10.1016/j.biomaterials.2021.120842. Epub 2021 May 1.
7
Design and Evaluation of An Extended-Release Olmesartan Tablet Using Chitosan/Cyclodextrin Composites.使用壳聚糖/环糊精复合材料的缓释奥美沙坦片剂的设计与评价
Pharmaceutics. 2019 Feb 15;11(2):82. doi: 10.3390/pharmaceutics11020082.